Joyce-Shaikh; Barbara
Patent Applications and Registrations
Patent applications and USPTO patent grants for Joyce-Shaikh; Barbara.The latest application filed is for "anti-ilt4 antibodies and antigen-binding fragments".
- Joyce-Shaikh; Barbara - San Jose CA US
- JOYCE-SHAIKH; Barbara - Palo Alto CA US
| Patent | Date |
|---|---|
| ILT3 ligand Grant 11,370,839 - Cua , et al. June 28, 2 | 2022-06-28 |
| Anti-ilt4 Antibodies And Antigen-binding Fragments App 20220033496 - BLANUSA; Milan ; et al. | 2022-02-03 |
| Anti-ilt4 Antibodies And Antigen-binding Fragments App 20220002403 - Blanusa; Milan ; et al. | 2022-01-06 |
| Anti-ILT4 antibodies and antigen-binding fragments Grant 11,053,315 - Joyce-Shaikh , et al. July 6, 2 | 2021-07-06 |
| Ilt3 Ligand App 20190241655 - Cua; Daniel ; et al. | 2019-08-08 |
| Anti-ILT4 Antibodies and Antigen-Binding Fragments App 20180298096 - Joyce-Shaikh; Barbara ; et al. | 2018-10-18 |
| MDL-1 ligand Grant 9,284,377 - Joyce-Shaikh , et al. March 15, 2 | 2016-03-15 |
| Mdl-1 Ligand App 20150368344 - Joyce-Shaikh; Barbara ; et al. | 2015-12-24 |
| Modulation of PILR to Treat Immune Disorders App 20140234301 - Tato; Cristina M. ; et al. | 2014-08-21 |
| Mdl-1 Ligand App 20140227719 - Joyce-Shaikh; Barbara ; et al. | 2014-08-14 |
| Methods of treating multiple sclerosis, rheumatoid arthritis and inflammatory bowel disease using agonists antibodies to PILR-.alpha. Grant 8,691,227 - Tato , et al. April 8, 2 | 2014-04-08 |
| Use Of Mdl-1 Antagonists To Treat Spondylarthropathy App 20130323246 - Cua; Daniel J. ; et al. | 2013-12-05 |
| Modulation Of Pilr To Treat Immune Disorders App 20130071380 - Tato; Cristina M. ; et al. | 2013-03-21 |
| Mdl-1 Uses App 20120177647 - Bigler; Michael E. ; et al. | 2012-07-12 |
| Mdl-1 Uses App 20100221252 - Bigler; Michael E ; et al. | 2010-09-02 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 